Maria Diab is a Hematology physician affiliated with Henry Ford Health. OpenAlex indexes 72 publications with 2,448 citations (h-index 13); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer
Sponsor: Emory University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GileadProgram year20252 paymentsResearch$197,188openpaymentsdata.cms.gov ↗
- Jazz PharmaceuticalsProgram year20254 paymentsResearch$42,800openpaymentsdata.cms.gov ↗
- GSKProgram year20258 paymentsResearch$38,050openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Outcomes with adjuvant chemotherapy in patients with early-stage biliary tract cancers: An NCDB analysis.
Journal of Clinical Oncology
2026 - Real-world outcomes in gastrointestinal cancer patients with targetable genomic alterations identified on serial liquid biopsy.
Journal of Clinical Oncology
2026 - Outcomes of combined HCC-cholangiocarcinoma with adjuvant chemotherapy: An NCDB cohort.
Journal of Clinical Oncology
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Philip, MD
Henry Ford Health
David Lanfear, MD
Henry Ford Health
David Ozog, MD
Henry Ford Health
Jessica Mellinger, MD
Henry Ford Health
Joseph Antin, MD
Harvard University
Scott Kaufmann, MD
Mayo Clinic College of Medicine
Ruben Mesa, MD
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Jaroslaw Maciejewski, MD
Cleveland Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”